United States Healthcare Burden of Pediatric Functional Gastrointestinal Pain Disorder Hospitalizations from 2002 to

John M Hollier1,2, Jason L Salemi3,4, Robert J Shulman1,2,5

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Insights

Pediatric functional gastrointestinal disorder hospitalizations decreased recently, but constipation admissions rose. Costs increased due to procedures, highlighting a need for further research into these trends.

Area of Science:

  • Pediatric Gastroenterology
  • Health Services Research
  • Epidemiology

Background:

  • The healthcare burden of pediatric functional gastrointestinal pain disorders (FGIDs) in the US remains poorly understood.
  • Characterizing the hospitalization burden is crucial for resource allocation and patient care.

Purpose of the Study:

  • To analyze the trends in prevalence, length of stay, and costs of pediatric FGID hospitalizations in the United States from 2002 to 2018.
  • To identify demographic disparities and common interventions associated with these hospitalizations.

Main Methods:

  • Utilized the US National Inpatient Sample (NIS) data from 2002-2018.
  • Included pediatric hospitalizations (ages 4-18) with primary FGID diagnoses.
  • Analyzed prevalence rates, length of stay (LOS), inflation-adjusted costs, and intervention trends using joinpoint analyses.

Main Results:

  • 1 in 64 pediatric hospitalizations were for FGIDs, with overall prevalence decreasing from 2013-2018.
  • Constipation admissions increased significantly, particularly among younger non-Hispanic Blacks and Hispanics.
  • Average LOS stabilized recently, but costs per hospitalization increased, driven by endoscopic procedures.

Conclusions:

  • Recent decreases in FGID hospitalization rates may reflect healthcare policy changes.
  • Rising constipation admissions and increasing costs necessitate further investigation.
  • Endoscopic procedures are a significant cost driver, warranting closer examination.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
186
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
29
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
659
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
234